Tirofiban for Reduction of TEAR: A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1161/STROKEAHA.126.056558
文献链接: https://www.ahajournals.org/doi/10.1161/STROKEAHA.126.056558
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Xinyan Hu; Qianmei Jiang; Ning Wang; Qi Liu; Shilin Li; Pengzhan Wang; Chen Ling; Anxin Wang; Zhe Zhang; Jianying Cao; Xinjian Yang; Yongjun Wang; Xuewei Xie; Jing Jing; Lian Liu

